Delivery Order SPE2DR25D2104-SPE2DR26F3RJD
- Not listed
- The Defense Logistics Agency awarded a $2,652.67 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 400 mg capsules (180 count) on November 25, 2025, with completion scheduled for November 26, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a $7,361.02 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mesalamine 400 mg capsules (180-count units). This non-set-aside contract features firm fixed pricing and is scheduled for completion by July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a $8,989.14 delivery order to AmerisourceBergen Drug Corp for 180 capsules of Mesalamine 400 mg on December 12, 2025, with an ultimate completion date of December 15, 2025. This is a firm fixed-price contract with no set-aside designation, issued as a competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations center. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,353.73 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count) with a firm fixed price arrangement. The order was competitively awarded without set-aside designation and is scheduled for completion by September 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, serving the federal government's...
- The Defense Logistics Agency awarded a $4,928.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units), with performance in Conshohocken, Pennsylvania and a completion deadline of December 2, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.999 billion ceiling...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $14,506.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine 1.2GM (120 count) with an ultimate completion date of October 15, 2025. The award, issued on September 17, 2025, was competitively awarded with no set-aside designation. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 14, 2025, for the supply of Mesalamine DR 400 mg capsules (180 count) valued at $9,632.65. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 17, 2025. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,724.60 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mesalamine DR 400 mg capsules (180 count). The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not set aside for any particular business category and was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $2,882.72 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180 count) under a firm fixed price contract. The order was competitively awarded without a set-aside designation and is scheduled for completion by June 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,704.12 to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180 count) with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3RJDDelivery Order
The Defense Logistics Agency awarded a $5,911.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 capsules of Mesalamine 400 mg, with an ultimate completion date of December 15, 2025. This non-set-aside contract represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, serving as the prime contractor on this delivery order. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains. The contract supports the Defense Health Agency and other government healthcare systems requiring pharmaceutical commodities for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 12/11/25 |